Met-Tara Injection Substitute
by Others
by Others
by Others
by Others
by Others
by Others
by AYUR
by Others
Composition:
METRONIDAZOLE-500MG
Uses:
Met-Tara Injection used in the treatment of bacterial infections. The detailed uses of Met-Tara Injection are as follows: <br/>• Treatment of Infections: Met-Tara Injection effectively treats various infections, including intra-abdominal, skin, gynecologic, septicemia, bone and joint, CNS, respiratory tract, and endocarditis, by eliminating anaerobic bacteria and parasites, stopping their growth, and alleviating symptoms.<br/>• Surgical Prophylaxis: Met-Tara Injection is used as a surgical prophylaxis to prevent postoperative infections, particularly for surgeries involving the gastrointestinal tract.<br/>• Management of Clostridium Difficile Infection: Met-Tara Injection is used to manage severe Clostridium difficile infections, especially when oral medication is not possible.<br/>• Amoebic Dysentery Treatment: Met-Tara Injection is used to treat amoebic dysentery, a severe intestinal infection caused by the Entamoeba histolytica parasite.<br/>• Combination Therapy: Met-Tara Injection is often used in combination with other antibiotics to treat serious infections, offering a broad spectrum of action and enhancing treatment effectiveness.<br/>
Medicinal Benefits:
Met-Tara Injection belongs to a group of medicines known as anti-bacterial agents used to treat severe bacterial infections of the bone, skin and skin structure, blood, joint, abdomen, central nervous system, gynecologic, respiratory infections, meningitis (infection of the membranes that surround the brain and spinal cord), and endocarditis (infection of the heart lining and valves). Met-Tara Injection contains Metronidazole, which suppresses protein synthesis by interacting with DNA and causes helical DNA structure loss and strand breakage. As a result, it induces cell death in susceptible organisms. Thereby, Met-Tara Injection treats bacterial infections.
Met-Tara Injection belongs to a group of medicines known as antibacterial agents used to treat severe bacterial infections of the bone, skin and skin structure, blood, joint, abdomen, central nervous system, respiratory, and gynaecological systems, meningitis (infection of the membranes that surround the brain and spinal cord), and endocarditis (infection of the heart lining and valves).
Met-Tara Injection suppresses protein synthesis by interacting with DNA, causing helical DNA structure loss and strand breakage. As a result, it induces cell death in susceptible organisms, treating bacterial infections.
Caution should be exercised. Met-Tara Injection may enhance the anticoagulant activity of warfarin and other oral anticoagulants by extending prothrombin time. Inform your doctor if you are taking such medications.
No. Met-Tara Injection is an antibacterial medicine that acts only against bacterial infections, not viral infections like the common cold and flu.
Met-Tara Injection should only be used to treat or prevent infections that have been proven or are strongly suspected to be caused by susceptible anaerobic bacteria.
Extreme caution should be exercised while using Met-Tara Injection in patients with severe liver damage, blood formation disorder, brain, spinal cord or nervous disease. So, let your doctor know if you have any of these conditions.